Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
6 participants
INTERVENTIONAL
2023-08-14
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stellate Ganglion Block for PTSD
NCT05169190
Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD
NCT02268084
Neurofeedback Prevention For Early Stress Related Adversity
NCT02477722
Neural Correlates of Cognitive Rehabilitation in Post-Traumatic Stress Disorder (PTSD)
NCT00928941
EEG Biofeedback in the Treatment of Chronic Treatment-Resistant PTSD
NCT01259921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There will be a single cohort in the study consisting of the subjects with PTSD who will receive treatment with NeuroGlove.
The trial is intended to evaluate the impact of the device use on active PTSD symptoms and subject sense of well-being.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NeuroGlove Treatment Arm
Study participants undergoing treatment using the NeuroGlove.
NeuroGlove
Study participant with PTSD will undergo daily at home treatment using the NeuroGlove.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeuroGlove
Study participant with PTSD will undergo daily at home treatment using the NeuroGlove.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women ≥18 and \<85 years of age.
* Carry an active diagnosis of PTSD.
* Suffer from PTSD symptoms that impact subject's daily activities and quality of life.
Exclusion Criteria
* Subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
* Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NeuroGlove LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Nussbaum, MD
Role: PRINCIPAL_INVESTIGATOR
NeuroGlove LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NeuroGlove
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG-1003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.